MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance

Hyojin Eom, Neha Kaushik, Ki Chun Yoo, Jin Kyoung Shim, Munjin Kwon, Mi Young Choi, Taeyoung Yoon, Seok Gu Kang, Su Jae Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multiforme (GBM) in comparison to its healthy counterpart and is implicated in brain tumorigenesis. Clarifying the underlying mechanism of MerTK induced invasiveness would result in novel strategies to improve patient’s response to chemotherapeutics. In vitro and in vivo assays were performed to examine the functional role of cancer stem sell (CSC) maintenance in MerTK associated invasiveness. In this article, we demonstrate that apart from GBM cells, MerTK is also upregulated in GBM stem-like cells and associated with an increased infiltrative potential of brain tumors in vivo. Silencing of MerTK suppressed the self-renewal of patient-derived GBM stem-like cells. The signaling mechanisms by which MerTK contributes to CSC maintenance have largely been obscure. Molecular analyses revealed that high expression of the signal transducer and activator of transcription 3 (STAT3)- Kirsten rat sarcoma viral oncogene homolog (KRAS) and proto-oncogene tyrosine-protein kinase SRC axis supports MerTK-induced CSC maintenance in GBM spheroids. Furthermore, a short-hairpin RNA-mediated MerTK knockdown effectively blocked invasiveness and N-cadherin expression in mouse xenografts. Collectively, our results uncover a critical function of MerTK in CSC maintenance. Considering the low basal level of MerTK expression in healthy brain cells, evaluation of MerTK as a therapeutic target should advance the research into better therapeutics for GBM.

Original languageEnglish
Pages (from-to)87-95
Number of pages9
JournalArtificial Cells, Nanomedicine and Biotechnology
Volume46
Issue numbersup2
DOIs
Publication statusPublished - 2018 Nov 5

Fingerprint

Glioblastoma
Stem cells
Glioma
Stem Cells
Maintenance
Brain
Proto-Oncogene Proteins
Transcription
RNA
Rats
Tumors
Transducers
STAT3 Transcription Factor
Assays
Receptor Protein-Tyrosine Kinases
Cadherins
Proteins
Oncogenes
Heterografts
Brain Neoplasms

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Pharmaceutical Science

Cite this

Eom, Hyojin ; Kaushik, Neha ; Yoo, Ki Chun ; Shim, Jin Kyoung ; Kwon, Munjin ; Choi, Mi Young ; Yoon, Taeyoung ; Kang, Seok Gu ; Lee, Su Jae. / MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance. In: Artificial Cells, Nanomedicine and Biotechnology. 2018 ; Vol. 46, No. sup2. pp. 87-95.
@article{defacc537cb346c28c546cd4689593f9,
title = "MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance",
abstract = "Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multiforme (GBM) in comparison to its healthy counterpart and is implicated in brain tumorigenesis. Clarifying the underlying mechanism of MerTK induced invasiveness would result in novel strategies to improve patient’s response to chemotherapeutics. In vitro and in vivo assays were performed to examine the functional role of cancer stem sell (CSC) maintenance in MerTK associated invasiveness. In this article, we demonstrate that apart from GBM cells, MerTK is also upregulated in GBM stem-like cells and associated with an increased infiltrative potential of brain tumors in vivo. Silencing of MerTK suppressed the self-renewal of patient-derived GBM stem-like cells. The signaling mechanisms by which MerTK contributes to CSC maintenance have largely been obscure. Molecular analyses revealed that high expression of the signal transducer and activator of transcription 3 (STAT3)- Kirsten rat sarcoma viral oncogene homolog (KRAS) and proto-oncogene tyrosine-protein kinase SRC axis supports MerTK-induced CSC maintenance in GBM spheroids. Furthermore, a short-hairpin RNA-mediated MerTK knockdown effectively blocked invasiveness and N-cadherin expression in mouse xenografts. Collectively, our results uncover a critical function of MerTK in CSC maintenance. Considering the low basal level of MerTK expression in healthy brain cells, evaluation of MerTK as a therapeutic target should advance the research into better therapeutics for GBM.",
author = "Hyojin Eom and Neha Kaushik and Yoo, {Ki Chun} and Shim, {Jin Kyoung} and Munjin Kwon and Choi, {Mi Young} and Taeyoung Yoon and Kang, {Seok Gu} and Lee, {Su Jae}",
year = "2018",
month = "11",
day = "5",
doi = "10.1080/21691401.2018.1452022",
language = "English",
volume = "46",
pages = "87--95",
journal = "Artificial Cells, Nanomedicine and Biotechnology",
issn = "2169-1401",
publisher = "Informa Healthcare",
number = "sup2",

}

MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance. / Eom, Hyojin; Kaushik, Neha; Yoo, Ki Chun; Shim, Jin Kyoung; Kwon, Munjin; Choi, Mi Young; Yoon, Taeyoung; Kang, Seok Gu; Lee, Su Jae.

In: Artificial Cells, Nanomedicine and Biotechnology, Vol. 46, No. sup2, 05.11.2018, p. 87-95.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MerTK mediates STAT3–KRAS/SRC-signaling axis for glioma stem cell maintenance

AU - Eom, Hyojin

AU - Kaushik, Neha

AU - Yoo, Ki Chun

AU - Shim, Jin Kyoung

AU - Kwon, Munjin

AU - Choi, Mi Young

AU - Yoon, Taeyoung

AU - Kang, Seok Gu

AU - Lee, Su Jae

PY - 2018/11/5

Y1 - 2018/11/5

N2 - Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multiforme (GBM) in comparison to its healthy counterpart and is implicated in brain tumorigenesis. Clarifying the underlying mechanism of MerTK induced invasiveness would result in novel strategies to improve patient’s response to chemotherapeutics. In vitro and in vivo assays were performed to examine the functional role of cancer stem sell (CSC) maintenance in MerTK associated invasiveness. In this article, we demonstrate that apart from GBM cells, MerTK is also upregulated in GBM stem-like cells and associated with an increased infiltrative potential of brain tumors in vivo. Silencing of MerTK suppressed the self-renewal of patient-derived GBM stem-like cells. The signaling mechanisms by which MerTK contributes to CSC maintenance have largely been obscure. Molecular analyses revealed that high expression of the signal transducer and activator of transcription 3 (STAT3)- Kirsten rat sarcoma viral oncogene homolog (KRAS) and proto-oncogene tyrosine-protein kinase SRC axis supports MerTK-induced CSC maintenance in GBM spheroids. Furthermore, a short-hairpin RNA-mediated MerTK knockdown effectively blocked invasiveness and N-cadherin expression in mouse xenografts. Collectively, our results uncover a critical function of MerTK in CSC maintenance. Considering the low basal level of MerTK expression in healthy brain cells, evaluation of MerTK as a therapeutic target should advance the research into better therapeutics for GBM.

AB - Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multiforme (GBM) in comparison to its healthy counterpart and is implicated in brain tumorigenesis. Clarifying the underlying mechanism of MerTK induced invasiveness would result in novel strategies to improve patient’s response to chemotherapeutics. In vitro and in vivo assays were performed to examine the functional role of cancer stem sell (CSC) maintenance in MerTK associated invasiveness. In this article, we demonstrate that apart from GBM cells, MerTK is also upregulated in GBM stem-like cells and associated with an increased infiltrative potential of brain tumors in vivo. Silencing of MerTK suppressed the self-renewal of patient-derived GBM stem-like cells. The signaling mechanisms by which MerTK contributes to CSC maintenance have largely been obscure. Molecular analyses revealed that high expression of the signal transducer and activator of transcription 3 (STAT3)- Kirsten rat sarcoma viral oncogene homolog (KRAS) and proto-oncogene tyrosine-protein kinase SRC axis supports MerTK-induced CSC maintenance in GBM spheroids. Furthermore, a short-hairpin RNA-mediated MerTK knockdown effectively blocked invasiveness and N-cadherin expression in mouse xenografts. Collectively, our results uncover a critical function of MerTK in CSC maintenance. Considering the low basal level of MerTK expression in healthy brain cells, evaluation of MerTK as a therapeutic target should advance the research into better therapeutics for GBM.

UR - http://www.scopus.com/inward/record.url?scp=85044209799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044209799&partnerID=8YFLogxK

U2 - 10.1080/21691401.2018.1452022

DO - 10.1080/21691401.2018.1452022

M3 - Article

C2 - 29553850

AN - SCOPUS:85044209799

VL - 46

SP - 87

EP - 95

JO - Artificial Cells, Nanomedicine and Biotechnology

JF - Artificial Cells, Nanomedicine and Biotechnology

SN - 2169-1401

IS - sup2

ER -